论文部分内容阅读
AIM:To assess the efficacy and safety of bone marrow-derived mesenchymal stem cell(BM-MSC) in the treatment of decompensated liver cirrhosis.METHODS:The search terms 'bone marrow stem cell' 'chronic liver disease' 'transfusion' and